Sen. Kyrsten Sinema has received almost $100,000 from drug companies in the current election cycle, a KHN analysis shows, one of the largest cash hauls in Congress. And it’s only her first term.
Three senators on a revived subcommittee received more than $100,000 each from drugmakers.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.